About 40.4% of participants lost 25% or more of their starting body weight
Mild skin irritation may occur at the injection site
For semaglutide, common maintenance doses range from 0.25 mg to 1.0 mg weekly, down from the therapeutic 1.7 to 2.4 mg
Oncoimmunology 10 , 1956143 (2021)
The UK Summary of Product Characteristics (SmPC) for Wegovy and the British National Formulary (BNF) list no direct pharmacokinetic interactions between semaglutide and antidepressants, including SSRIs like sertraline
It is also seen to have anticancer, anti-osteoarthritis immunomodulatory, anti-diabetic, antiparasitic, antioxidant, and neuroprotective properties (Bakrim et al